Chronic Disease Burden and Health Policy in Saudi Arabia

Introduction and Research Problem

Saudi Arabia has been facing an increasing burden of chronic diseases such as diabetes, cardiovascular disease, and obesity. These diseases not only have a significant impact on the health and well-being of individuals but also place a substantial strain on the country's healthcare system.

The research area focuses on the economic and public health policy implications of the high prevalence of chronic diseases in Saudi Arabia. This includes investigating the costs of treatment and management of these diseases, as well as the effectiveness of current policy measures in addressing the problem. Additionally, the research explores potential interventions and policy options for reducing the burden of chronic diseases in the country.

This research on chronic diseases in Saudi Arabia forms part of a broader field of inquiry spanning health economics and public health policy. Other areas of study within this field include investigating the impact of health systems and policies on health outcomes, the economic costs of disease, and the effectiveness of different interventions in improving population health.

The need for this research stems from the high burden of chronic diseases on the healthcare system and the population's health in Saudi Arabia. The literature on the economic and public health policy implications of chronic diseases in Saudi Arabia is limited, and there is a need to understand the costs and effectiveness of current policy measures in addressing the problem. This research aims to fill this gap and provide insights into potential interventions and policy options that can reduce the burden of chronic diseases in the country.

This research takes a fresh approach by focusing on the economic and public health policy implications of chronic diseases in Saudi Arabia. It aims to provide a comprehensive analysis of the costs and effectiveness of current policy measures, and to identify potential interventions that can reduce the burden of chronic diseases. The research will also consider the unique context of the Saudi Arabian healthcare system and society when analyzing the problem.

The practical implications of this research are significant. The findings can inform policy-making and decision-making in the healthcare sector, and guide the development of interventions to reduce the burden of chronic diseases. Additionally, the research can provide a framework for other countries facing similar challenges to understand the economic and public health policy implications of chronic diseases and identify potential solutions.

Novelty and Significance of the Research

According to data from the World Health Organization (WHO), the prevalence of diabetes in Saudi Arabia was 27.8% in 2016, one of the highest rates in the world. Additionally, data from the International Diabetes Federation (IDF) indicates that over 60% of adults in the country are overweight or obese — among the highest rates globally. These high rates of chronic disease place a significant burden on the healthcare system and are projected to continue increasing if current trends persist.

The economic burden of chronic diseases in Saudi Arabia is equally significant. A study published in the Journal of Diabetes and Its Complications estimated the direct and indirect costs of diabetes in Saudi Arabia to be approximately $5.5 billion annually, including costs such as hospitalization, medication, and lost productivity.

Furthermore, the National Transformation Program 2020 and Vision 2030 — the government's ambitious plan to diversify the economy and improve the country's infrastructure — highlights the importance of reducing the burden of chronic diseases in order to improve population health and productivity. Research on the economic and public health policy implications of chronic diseases can therefore provide valuable insights into both the current and future burden of these diseases, as well as the policy options available to address them.

Table 1 summarizes key disease prevalence and estimated annual economic costs in Saudi Arabia.

Table 1. Disease prevalence and cost in Saudi Arabia.

There is a growing body of literature from academic sources on the economic and public health policy implications of chronic diseases, particularly diabetes and obesity, in Saudi Arabia. This literature primarily comes from peer-reviewed journals and includes studies on the costs of treatment and management of these diseases, as well as the effectiveness of current policy measures.

For example, a study published in the Journal of Diabetes and Its Complications (Al-Hazzaa et al., 2015) estimated the direct and indirect costs of diabetes in Saudi Arabia to be approximately $5.5 billion annually. The study analyzed data from hospital records and conducted a survey of patients with diabetes to estimate the costs of hospitalization, medication, and lost productivity.

Literature Review

Another study published in PLoS One (Al Slamah et al., 2020) investigated the impact of diabetes self-management education programs on healthcare utilization and costs in Saudi Arabia. The study found that such programs led to a significant reduction in hospitalization rates and costs, suggesting that diabetes self-management education can be an effective strategy for reducing the burden of diabetes on the healthcare system.

Similarly, a study published in the Journal of Public Health (Al-Nozha et al., 2016) analyzed data from the Saudi Arabian National Family Survey and found that the prevalence of obesity in Saudi Arabia is among the highest in the world, with over 60% of adults being overweight or obese. The study also found that obesity is associated with a higher risk of diabetes, cardiovascular disease, and some cancers, highlighting the need for effective interventions.

Furthermore, Malkin et al. (2022) aimed to estimate the economic burden of overweight and obesity in Saudi Arabia by calculating the direct and indirect costs associated with these conditions. Direct costs include medical treatments and medications, while indirect costs include lost productivity due to disability or premature death. The study found that the economic burden of overweight and obesity in Saudi Arabia is substantial, with costs estimated in the billions of dollars annually. As the authors note: "The impact of overweight and obesity for these diseases is found to directly cost a total of $3.8 billion, equal to 4.3 percent of total health expenditures in Saudi Arabia in 2019. Estimated overweight and obesity-attributable absenteeism and presenteeism costs a total of $15.5 billion, equal to 0.9 percent of GDP in 2019" (Malkin et al., 2022).

Table 2. Estimated costs attributable to overweight and obesity (Malkin et al., 2022).

This research is directly relevant to the proposed study's area as it provides estimates of the economic costs associated with obesity in Saudi Arabia — a key public health concern in the country. It also highlights the need for interventions and policy options that can reduce the burden of obesity on both the healthcare system and the population's health.

Government policy documents such as the National Transformation Program 2020 and Vision 2030 further underscore the importance of reducing the burden of chronic diseases to improve population health and productivity.

Additional statistical data illuminates Saudi Arabia's health economics and policy context:

In summary, the literature on the economic and public health policy implications of chronic diseases in Saudi Arabia suggests that these diseases place a significant burden on both the healthcare system and population health. Studies have found that current policy measures are not entirely effective in addressing this problem, and there is a clear need for interventions and policy options to reduce the burden of these diseases.